Arcadia Biosciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024: -246.05%

Arcadia Biosciences, Inc. Operating Income Margin is -246.05% for the Trailing 12 Months (TTM) ending March 31, 2024, a 6.58% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Arcadia Biosciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -230.86%, a -39.19% change year over year.
  • Arcadia Biosciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -379.66%, a 163.70% change year over year.
  • Arcadia Biosciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -143.97%, a -90.93% change year over year.
  • Arcadia Biosciences, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2020 was -1,587.35%, a 29.57% change year over year.
Key Data
Date Operating Income Margin Gross Profit Margin EBIT Margin EBITDA Margin